Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Added to Topical Treatment in Mild to Moderate Atopic Dermatitis
NCT07713186Phase 4Not yet recruiting
- Sponsor
- Cairo University
- Start
- Aug 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 4, randomised trial of azithromycin in atopic dermatitis (AD) (2 arms), sponsored by Cairo University. Primary endpoint: Eczema Area and Severity Index at 3 months. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07713186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07713186.